# OXYTROL
> **NDA021351** · New Drug Application · Sponsor: ALLERGAN · Approved 2003-02-26
## Drug
- **FDA Application Number:** NDA021351
- **Application type:** New Drug Application
- **Brand name:** OXYTROL
- **Generic name:** OXYBUTYNIN
- **Active ingredients:** OXYBUTYNIN
- **Dosage form:** FILM, EXTENDED RELEASE
- **Route:** TRANSDERMAL
- **Marketing status:** Prescription
- **Sponsor:** ALLERGAN
- **Manufacturer:** Allergan, Inc.
- **First approval:** 2003-02-26
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021351)
---
*AI Analytics · CC0 1.0*